GlassScriptPhysician profile
Mark L Hagood
NPI 1477507408
$2,941.11
in general payments reported to CMS, 2019-2025
24 companies · $505 in 2025
The $505 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $71.99 · 2021: $346 · 2022: $540 · 2023: $532 · 2024: $624 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,660.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $670.72 | 2019-2023 | Trudi Nav Cable |
| Regeneron Healthcare Solutions, INC. | $538.98 | 2019-2025 | Dupixent |
| Genzyme Corporation | $490.26 | 2019-2025 | |
| Glaxosmithkline, LLC. | $229.56 | 2023-2025 | Nucala |
| Stryker Corporation | $227.56 | 2019-2025 | Xpress Loprofile |
| Aerin Medical INC. | $115.50 | 2024 | |
| Ethicon US, LLC | $111.66 | 2019 | |
| Intersect Ent, INC. | $87.48 | 2019-2021 | |
| Optinose US, INC. | $67.36 | 2021-2024 | |
| Medtronic, INC. | $62.87 | 2023-2025 | Propel |
| Kerecis Limited | $48.21 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Polynovo North America LLC | $44.74 | 2022-2023 | |
| Integra Lifesciences Corporation | $43.87 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Merck Sharp & Dohme LLC | $40.93 | 2023 | |
| Inspire Medical Systems, INC. | $21.55 | 2025 | Inspire |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $20.92 | 2024 | Halo |
| Cochlear Americas | $19.47 | 2020 | |
| Arbor Pharmaceuticals, INC. | $16.31 | 2020 | |
| Allergan, INC. | $16.02 | 2019 | |
| Neurent Medical Limited | $14.85 | 2023 | Neuromark Device, Neuromark Radiofrequency Console |
| Ambu INC. | $14.44 | 2025 | |
| Hologic Sales and Service, LLC | $13.69 | 2024 | Coolseal Generator |
| Hikma Pharmaceuticals USA | $13.58 | 2023 | Ryaltris |
| Phathom Pharmaceuticals, INC. | $10.58 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hagood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.